SCHEMBL4398997

SCHEMBL4398997

Cc1cccc[n+]1CCOCCOCCOCC[n+]1ccccc1C

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.60
NPC1 O15118 1/20 0.60
POLB P06746 1/20 0.60
RAB9A P51151 1/20 0.60
BCHE P06276 5/20 0.50
ACHE P22303 4/20 0.50
KMT2A Q03164 3/20 0.40
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
LMNA P02545 3/20 0.33
MEN1 O00255 2/20 0.33
MMP14 P50281 1/20 0.33
THRB P10828 1/20 0.33
KDM4E B2RXH2 2/20 0.32
SLC19A2 O60779 1/20 0.32
USP2 O75604 1/20 0.32
CASP1 P29466 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ALDH1A1 P00352 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2177183 0.98 SMN1; SMN2 (0.58) SMN1; SMN2NPC1POLBRAB9ABCHE
Hydrochloric Acid SCHEMBL3311343 0.86 SMN1; SMN2 (0.54) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL31482686 0.77 RAB9A (0.67) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL3603641 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL4890046 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL3600997 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL3606677 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL3598215 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL3592351 0.77 NPC1 (0.96) SMN1; SMN2NPC1POLBRAB9ABCHE
SCHEMBL2860482 0.77 RAB9A (0.67) SMN1; SMN2NPC1POLBRAB9ABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8178678-B2 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2012-05-15 US disclosed
US-8178678-B2 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2012-05-15 US disclosed
US-20100069432-A1 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-03-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069432-A1 Bis-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors CHRNA2, CHRNA5, CHRNA4 SMN1; SMN2 1447/4885NPC1 1844/4885POLB 3604/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.